<bill session="117" type="h" number="1024" updated="2023-01-11T13:47:25Z">
  <state datetime="2021-02-11">REFERRED</state>
  <status>
    <introduced datetime="2021-02-11"/>
  </status>
  <introduced datetime="2021-02-11"/>
  <titles>
    <title type="display">COVID&#226;&#8364;&#8220;19 Supply Chain Resiliency Act of 2021</title>
    <title type="official" as="introduced">To establish the Office of COVID-19 Supply Chain Resiliency, and for other purposes.</title>
    <title type="short" as="introduced">COVID&#226;&#8364;&#8220;19 Supply Chain Resiliency Act of 2021</title>
  </titles>
  <sponsor bioguide_id="S001190"/>
  <cosponsors>
    <cosponsor bioguide_id="A000376" joined="2021-02-22"/>
    <cosponsor bioguide_id="A000378" joined="2021-02-22"/>
    <cosponsor bioguide_id="C001119" joined="2021-02-25"/>
    <cosponsor bioguide_id="J000301" joined="2021-02-11"/>
  </cosponsors>
  <actions>
    <action datetime="2021-02-11">
      <text>Introduced in House</text>
    </action>
    <action datetime="2021-02-11" state="REFERRED">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
    <action datetime="2021-02-12">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSIF" name="House Energy and Commerce" subcommittee="" activity="Referral"/>
    <committee code="HSIF14" name="House Energy and Commerce" subcommittee="Health" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Commerce"/>
    <term name="Cardiovascular and respiratory health"/>
    <term name="Congressional oversight"/>
    <term name="Emergency medical services and trauma care"/>
    <term name="Executive Office of the President"/>
    <term name="Executive agency funding and structure"/>
    <term name="Federal officials"/>
    <term name="Food supply, safety, and labeling"/>
    <term name="Government studies and investigations"/>
    <term name="Health technology, devices, supplies"/>
    <term name="Infectious and parasitic diseases"/>
    <term name="Manufacturing"/>
    <term name="Strategic materials and reserves"/>
  </subjects>
  <amendments/>
  <summary date="2021-04-22T14:40:09Z" status="Introduced in House">COVID-19 Supply Chain Resiliency Act of 2021

This bill establishes the Office of COVID-19 Supply Chain Resiliency to identify and address supply chain issues related to the COVID-19 (i.e., coronavirus disease 2019) pandemic.

Specifically, the office must establish a national strategy to address identified supply chain issues related to the pandemic, serve as a central point of contact for and provide technical assistance to entities dealing with these issues, and develop legislative recommendations to strengthen critical supply chains for pandemics.

The office shall cease to exist 18 months after the COVID-19 public health emergency (and any renewal thereof) is terminated.</summary>
</bill>
